Acupressure Mat on Perceived Stress, Sleep Quality and Premenstrual Symptoms
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorGulhane School of Medicine
About this trial
Purpose of the study: To examine the effect of acupressure mat on perceived stress, sleep quality and premenstrual symptoms in students with premenstrual syndrome.
Hypotheses of the study;
In the post-test and follow-up test between students who were applied acupressure mat and those who were applied plain mat;
H10: There is no difference in terms of severity of premenstrual symptoms.
H20: There is no difference in terms of perceived stress.
H30: There is no difference in terms of sleep quality.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Using medication and/or non-medical methods to cope with PMS
Having any gynecological disease (abnormal uterine bleeding, myoma, ovarian cyst, etc.)
Using contraceptive medication.
Disqualifiers
Participants wanting to withdraw from the study at any stage of the study
Participants not complying with the research plan
Diagnosed with a psychiatric or gynecological disease during the study
Participants starting to receive additional treatment for PMS during the study period
Trial design
Design model
Parallel
Treatments tested in this trial
Acupresure mat
Other interventionThe Premenstrual Syndrome Scale will be applied and the scale results will be evaluated. Participants who score 132 and above on the scale will be considered to be experiencing PMS. The intervention will be made in the second phase of the study.This practice will continue for three menstrual cycles.
Basic mat
Other interventionThe Premenstrual Syndrome Scale will be applied and the scale results will be evaluated. Participants who score 132 and above on the scale will be considered to be experiencing PMS. The intervention will be made in the second phase of the study.Participants in this group will also be sent a reminder message similar to the intervention group. This practice will continue for three menstrual cycles.
Treatment groups
42 Participants
are divided into 2 treatment groupsGroup A: control groupPlacebo comparator 1 intervention
Group B: intervention groupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Premenstrual Syndrome Symptom Scale
It was developed by Gençdoğan (2006) to measure the severity of premenstrual symptoms. The scale consists of 44 questions that measure the severity of premenstrual symptoms based on DSM-III and DSM-IV-R. It is a five-point Likert-type scale. In the scoring of the scale, the option "Never" is given 1 point, the option "Very little" is given 2 points, and the option "Sometimes" is given 3 points.
Time frame
just before the application starts (pre-test), 12 weeks after the application starts (after the application ends/post-test) and 16 weeks later (follow-up test).2
Perceived Stress Scale
The scale was developed by Cohen et al. in 1983 to measure the stress a person perceives in a given situation and was adapted to Turkish by Eskin et al. (2013). The 5-point Likert-type scale (Never (0)-Very often (4)) contains a total of 14 items. 7 items with positive expressions are scored in reverse. The minimum score from 0 to a maximum of 56 points can be obtained from the scale. A high score indicates that the person is highly stressed.
Time frame
just before the application starts (pre-test), 12 weeks after the application starts (after the application ends/post-test) and 16 weeks later (follow-up test).3
Visual Analog Scale (VAS) Sleep Quality
Students will be asked to evaluate their sleep quality with the Visual Analog Scale. VAS-sleep quality is a 10 cm long tool. "My sleep quality is very poor" is written on the left end of the scale and "My sleep quality is very good" is written on the right. A score of 10 from the scale indicates that sleep quality is high, while a score of 0 indicates that sleep quality is very poor.
Time frame
just before the application starts (pre-test), 12 weeks after the application starts (after the application ends/post-test) and 16 weeks later (follow-up test).Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: